Filing Details

Accession Number:
0001181431-12-050225
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-09-12 21:40:22
Reporting Period:
2012-09-10
Filing Date:
2012-09-12
Accepted Time:
2012-09-12 20:40:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1059790 Pozen Inc POZN Pharmaceutical Preparations (2834) 621657552
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1135011 R John Plachetka C/O Pozen Inc.
1414 Raleigh Road, Suite 400
Chapel Hill NC 27517
President, Ceo And Chairman Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-09-10 187,500 $5.18 187,500 No 4 M Direct
Common Stock Disposition 2012-09-10 68,649 $6.29 118,851 No 4 S Direct
Common Stock Disposition 2012-09-11 73,851 $6.13 45,000 No 4 S Direct
Common Stock Disposition 2012-09-12 45,000 $6.04 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2012-09-10 187,500 $0.00 187,500 $5.18
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2013-01-02 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,819,442 Indirect By Trust (4)
Common Stock 227,250 Indirect By Trust (5)
Common Stock 1,157,808 Indirect By Silver Hill Investments, LLC (6)
Common Stock 32,088 Indirect By Trust (7)
Footnotes
  1. Reflects the weighted average price of 68,649 shares of common stock of Pozen Inc. sold by the reporting person in multiple transactions on 9/10/12 with sale prices ranging from $6.20 to $6.43 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  2. Reflects the weighted average price of 73,851 shares of common stock of Pozen Inc. sold by the reporting person in multiple transactions on 9/11/12 with sale prices ranging from $6.01 to $6.26 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  3. Reflects the weighted average price of 45,000 shares of common stock of Pozen Inc. sold by the reporting person in multiple transactions on 9/12/12 with sale prices ranging from $6.00 to $6.09 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  4. Beneficially owned by John R. Plachetka, indirectly, through the Revocable Declaration Trust u/a 1/31/2000, John R. Plachetka, Trustee.
  5. Beneficially owned by John R. Plachetka, indirectly, through the Revocable Declaration Trust u/a 1/31/2000, Clare A. Plachetka, Trustee.
  6. Beneficially owned by John R. Plachetka, indirectly, as manager of Silver Hill Investments, LLC. Silver Hill Investments LLC is 50% owned by the Family Trust under the John R. Plachetka Irrevocable Trust dated 4/20/2000, Wachovia Bank N.A. and Clare A. Plachetka, Trustees (the "Family Trust"); 40% owned by the Revocable Declaration of Trust u/a 1/31/2000, John R. Plachetka, Trustee; and 10% owned by the Revocable Declaration of Trust u/a 1/31/2000, Clare A. Plachetka, Trustee.
  7. Beneficially owned by John R. Plachetka, indirectly, through the Family Trust. The shares in the Family Trust are held in trust for the benefit of Clare A. Plachetka and John R. and Clare A. Plachetka's children.
  8. The option vested in four equal annual installments, with the initial vesting date occurring on January 2, 2004 and with the option expiring on January 2, 2013.